Courtesy of Bruker
begenius
April 11, 2025
Bruker announced a menu expansion of its validated PCR assays on its BeGenius sample-to-answer molecular diagnostics system, as well as automated sample preparation ...
ID 339643448 © Yuri Arcurs | Dreamstime.com
dreamstime_xxl_339643448
Jan. 30, 2025
The Roche Diagnostics Tina-quant Lipoprotein (a) Gen.2 Molarity assay is an in-vitro test measuring lipoprotein (a) in a person’s bloodstream (serum and plasma), and will be broadly...
ID 239686664 © Chernetskaya | Dreamstime.com
dreamstime_xxl_239686664
Jan. 24, 2025
FDA CLIA-waived tests broaden access to accurate, easy-to-use diagnostics for all patients in decentralized settings like urgent care centers, retail clinics, and community health...
Dec. 23, 2024
Extend the power of HPV testing BD Onclarity HPV Assay offers extended genotyping to identify high-risk HPV types beyond 16, 18, and 45 and is approved for self-collection in ...
curveimage
Nov. 13, 2024
As diabetes management evolves, the use of advanced testing technologies like ion-exchange high-performance liquid chromatography (HPLC) for A1C (or HbA1c) testing has become ...
Courtesy of Caris Life Sciences
PIQRAY® is a registered trademark of Novartis AG. VECTIBIX® is a registered trademark of Immunex Corporation. BRAFTOVI® is a registered trademark of Array BioPharma Inc. in the United States and various other countries. ERBITUX® is a registered trademark of ImClone LLC, a wholly owned subsidiary of Eli Lilly and Company. MEKINIST® is a registered trademark of Novartis AG Corporation Switzerland. KEYTRUDA® is a registered trademark of Merck. LENVIMA® (lenvatinib) is a registered trademark used by Eisai Inc. under license from Eisai R&D Management Co., Ltd.
Nov. 8, 2024
MI Cancer Seek is the first and only simultaneous whole exome and whole transcriptome-based assay with CDx indications for adults and pediatric patients.
Courtesy of Yourgene Health
yourgene_cystic_fibrosis_base_assay_ivdr
Oct. 18, 2024
Offers clinicians and patients additional confidence in quality and accuracy of test for cystic fibrosis diagnosis.
sekisui_header
Sept. 20, 2024
Accessible and Accurate Testing Solutions from Home to Lab by Sekisui Diagnostics.Sponsored by:
ID 314050690 © Svetlana Diacenco | Dreamstime.com
dreamstime_xxl_314050690
Sept. 19, 2024
QIAGEN adds over 100 new validated QIAcuity digital PCR assays for cancer research, inherited genetic disorders, infectious disease surveillance, and other applications.
hero_0924
Sept. 11, 2024
Clinical and Laboratory Standards Institute (CLSI) CEO Barb Jones shares how the global nonprofit’s standards, training and educational offerings prepare labs to meet the...
Courtesy of QuidelOrtho
7600_front_transparent